Cargando…
Assessment of HER2 testing patterns, HER2+ disease, and the utilization of HER2-directed therapy in early breast cancer
CONTEXT: Determining human epidermal growth factor receptor 2 (HER2) status is critical for the management of early-stage breast cancer (ESBC). An understanding of HER2 testing practices can provide insight into how test results influence the use of HER2-directed therapy. OBJECTIVE: To assess HER2 t...
Autores principales: | Stenehjem, David D, Yoo, Minkyoung, Unni, Sudhir K, Singhal, Mukul, Bauer, Hillevi, Saverno, Kim, Quah, Cheng, Masaquel, Anthony, Brixner, Diana I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4218922/ https://www.ncbi.nlm.nih.gov/pubmed/25378949 http://dx.doi.org/10.2147/BCTT.S69416 |
Ejemplares similares
-
Patterns of HER2 Gene Amplification and Response to Anti-HER2 Therapies
por: Vicario, Rocio, et al.
Publicado: (2015) -
The impact of HER2-directed targeted therapy on HER2-positive DCIS of the breast
por: Lewis, Gary. D., et al.
Publicado: (2021) -
Incidence and prognostic impact of HER2‐positivity loss after dual HER2‐directed neoadjuvant therapy for HER2+ breast cancer
por: LeVee, Alexis, et al.
Publicado: (2023) -
The role of HER2 and HER3 in HER2-amplified cancers beyond breast cancers
por: Majumder, Avisek, et al.
Publicado: (2021) -
HER kinase inhibition in patients with HER2- and HER3-mutant
cancers
por: Hyman, David M., et al.
Publicado: (2018)